Literature DB >> 28364452

Insomnia Patients With Objective Short Sleep Duration Have a Blunted Response to Cognitive Behavioral Therapy for Insomnia.

Christina J Bathgate1, Jack D Edinger1,2, Andrew D Krystal2.   

Abstract

Study
Objectives: This study examined whether individuals with insomnia and objective short sleep duration <6 h, a subgroup with greater risks of adverse health outcomes, differ in their response to cognitive-behavioral therapy for insomnia (CBT-I) when compared to individuals with insomnia and normal sleep duration ≥6 h.
Methods: Secondary analyses of a randomized, clinical trial with 60 adult participants (n = 31 women) from a single academic medical center. Outpatient treatment lasted 8 weeks, with a final follow-up conducted at 6 months. Mixed-effects models controlling for age, sex, CBT-I treatment group assignment, and treatment provider examined sleep parameters gathered via actigraphy, sleep diaries, and an Insomnia Symptom Questionnaire (ISQ) across the treatment and follow-up period.
Results: Six months post-CBT-I treatment, individuals with insomnia and normal sleep duration ≥6 h fared significantly better on clinical improvement milestones than did those with insomnia and short sleep duration <6 h. Specifically, individuals with insomnia and normal sleep duration had significantly higher insomnia remission (ISQ < 36.5; χ2[1, N = 60] = 44.72, p < .0001), more normative sleep efficiency (SE) on actigraphy (SE > 80%; χ2[1, N = 60] = 21, p < .0001), normal levels of middle of the night wake after sleep onset (MWASO) <31 minutes (χ2[1, N = 60] = 37.85, p < .0001), and a >50% decline in MWASO (χ2[1, N = 60] = 60, p < .0001) compared to individuals with insomnia and short sleep duration. Additionally, those with insomnia and normal sleep duration had more success decreasing their total wake time (TWT) at the 6-month follow-up compared to those with insomnia and short sleep duration (χ2[2, N = 60] = 44.1, p < .0001). Receiver-operating characteristic curve analysis found that using a 6-h cutoff with actigraphy provided a 95.7% sensitivity and 91.9% specificity for determining insomnia remission, with the area under the curve = 0.986. Conclusions: Findings suggest that individuals with insomnia and objective short sleep duration <6 h are significantly less responsive to CBT-I than those with insomnia and normal sleep duration ≥6 h. Using an actigraphy TST cutoff of 6 hours to classify sleep duration groups was highly accurate and provided good discriminant value for determining insomnia remission. © Sleep Research Society 2016. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Entities:  

Keywords:  actigraphy.; cognitive–behavioral therapy; insomnia; short sleep

Mesh:

Year:  2017        PMID: 28364452      PMCID: PMC6084751          DOI: 10.1093/sleep/zsw012

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  37 in total

1.  ROC curves, test accuracy, and the description of diagnostic tests.

Authors:  D Mossman; E Somoza
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1991       Impact factor: 2.198

Review 2.  Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder.

Authors:  Alexandros N Vgontzas; Julio Fernandez-Mendoza; Duanping Liao; Edward O Bixler
Journal:  Sleep Med Rev       Date:  2013-02-16       Impact factor: 11.609

3.  Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort.

Authors:  Julio Fernandez-Mendoza; Alexandros N Vgontzas; Duanping Liao; Michele L Shaffer; Antonio Vela-Bueno; Maria Basta; Edward O Bixler
Journal:  Hypertension       Date:  2012-08-14       Impact factor: 10.190

4.  Home is where sleep is: an ecological approach to test the validity of actigraphy for the assessment of insomnia.

Authors:  M Montserrat Sánchez-Ortuño; Jack D Edinger; Melanie K Means; Daniel Almirall
Journal:  J Clin Sleep Med       Date:  2010-02-15       Impact factor: 4.062

5.  An actigraphic comparison of sleep restriction and sleep hygiene treatments for insomnia in older adults.

Authors:  L Friedman; K Benson; A Noda; V Zarcone; D A Wicks; K O'Connell; J O Brooks; D L Bliwise; J A Yesavage
Journal:  J Geriatr Psychiatry Neurol       Date:  2000       Impact factor: 2.680

Review 6.  Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis.

Authors:  Francesco P Cappuccio; Lanfranco D'Elia; Pasquale Strazzullo; Michelle A Miller
Journal:  Diabetes Care       Date:  2009-11-12       Impact factor: 19.112

7.  Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007.

Authors:  Timothy Morgenthaler; Cathy Alessi; Leah Friedman; Judith Owens; Vishesh Kapur; Brian Boehlecke; Terry Brown; Andrew Chesson; Jack Coleman; Teofilo Lee-Chiong; Jeffrey Pancer; Todd J Swick
Journal:  Sleep       Date:  2007-04       Impact factor: 5.849

8.  Insomnia with objective short sleep duration is associated with a high risk for hypertension.

Authors:  Alexandros N Vgontzas; Duanping Liao; Edward O Bixler; George P Chrousos; Antonio Vela-Bueno
Journal:  Sleep       Date:  2009-04       Impact factor: 5.849

9.  Midlife insomnia and subsequent mortality: the Hordaland health study.

Authors:  Børge Sivertsen; Ståle Pallesen; Nick Glozier; Bjørn Bjorvatn; Paula Salo; Grethe S Tell; Reidun Ursin; Simon Øverland
Journal:  BMC Public Health       Date:  2014-07-15       Impact factor: 3.295

10.  Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder.

Authors:  Simon D Kyle; Christopher B Miller; Zoe Rogers; A Niroshan Siriwardena; Kenneth M Macmahon; Colin A Espie
Journal:  Sleep       Date:  2014-02-01       Impact factor: 5.849

View more
  27 in total

1.  A randomized controlled trial of digital cognitive behavioral therapy for insomnia in pregnant women.

Authors:  David A Kalmbach; Philip Cheng; Louise M O'Brien; Leslie M Swanson; Roopina Sangha; Srijan Sen; Constance Guille; Andrea Cuamatzi-Castelan; Alasdair L Henry; Thomas Roth; Christopher L Drake
Journal:  Sleep Med       Date:  2020-03-21       Impact factor: 3.492

Review 2.  The impact of stress on sleep: Pathogenic sleep reactivity as a vulnerability to insomnia and circadian disorders.

Authors:  David A Kalmbach; Jason R Anderson; Christopher L Drake
Journal:  J Sleep Res       Date:  2018-05-24       Impact factor: 3.981

3.  Predictors of cognitive behavioral therapy outcomes for insomnia in veterans with post-traumatic stress disorder.

Authors:  Ali A El-Solh; Nathan O'Brien; Morohunfolu Akinnusi; Sumit Patel; Leela Vanguru; Chathura Wijewardena
Journal:  Sleep Breath       Date:  2019-04-25       Impact factor: 2.816

4.  Cardiovascular autonomic dysfunction in insomnia patients with objective short sleep duration.

Authors:  Denise C Jarrin; Hans Ivers; Manon Lamy; Ivy Y Chen; Allison G Harvey; Charles M Morin
Journal:  J Sleep Res       Date:  2018-03-01       Impact factor: 3.981

5.  Frequency of Past and Current Psychiatric Disorders in Patients Referred for Polysomnography: A Pilot Study.

Authors:  Morgane Pradines; Marc Rey; Rémy Dumas; Wadih Rhondali; Patrick Lemoine; Jean-Michel Azorin; Christian Vedie
Journal:  J Clin Sleep Med       Date:  2018-09-15       Impact factor: 4.062

6.  Nocturnal cognitive arousal is associated with objective sleep disturbance and indicators of physiologic hyperarousal in good sleepers and individuals with insomnia disorder.

Authors:  David A Kalmbach; Daniel J Buysse; Philip Cheng; Thomas Roth; Alexander Yang; Christopher L Drake
Journal:  Sleep Med       Date:  2019-11-14       Impact factor: 3.492

Review 7.  Sleep disturbances in adolescents with ADHD: A systematic review and framework for future research.

Authors:  Jessica R Lunsford-Avery; Andrew D Krystal; Scott H Kollins
Journal:  Clin Psychol Rev       Date:  2016-10-23

Review 8.  Insomnia, Short Sleep Duration, and High Blood Pressure: Recent Evidence and Future Directions for the Prevention and Management of Hypertension.

Authors:  Christina J Bathgate; Julio Fernandez-Mendoza
Journal:  Curr Hypertens Rep       Date:  2018-05-19       Impact factor: 5.369

9.  Objective sleep disturbance is associated with poor response to cognitive and behavioral treatments for insomnia in postmenopausal women.

Authors:  David A Kalmbach; Philip Cheng; Thomas Roth; Chaewon Sagong; Christopher L Drake
Journal:  Sleep Med       Date:  2020-05-07       Impact factor: 3.492

10.  Use of Actigraphy for the Evaluation of Sleep Disorders and Circadian Rhythm Sleep-Wake Disorders: An American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment.

Authors:  Michael T Smith; Christina S McCrae; Joseph Cheung; Jennifer L Martin; Christopher G Harrod; Jonathan L Heald; Kelly A Carden
Journal:  J Clin Sleep Med       Date:  2018-07-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.